Cargando…

82. Assessment of Clinical Outcomes and Antibiotic Prescribing Patterns Following Implementation of the GenMark ePlex(®) Blood Culture Identification Panel for Gram-positive Bloodstream Infections

BACKGROUND: Rapid diagnostic testing (RDT) of bloodstream pathogens provides key information sooner than conventional identification and susceptibility testing. The GenMark ePlex® blood culture identification gram-positive (BCID-GP) panel is a molecular-based multiplex platform, with 20 Gram-positiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wein, Megan, Binkley, Shawn, Athans, Vasilios, Saw, Stephen, Lee, Tiffany, Patel, Sonal, Hamilton, Keith W, Binkley, Amanda, Degnan, Kathleen, Glaser, Laurel, Dutcher, Lauren, Talati, Naasha J, Richard-Greenblatt, Melissa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644650/ http://dx.doi.org/10.1093/ofid/ofab466.284

Ejemplares similares

1022. Evaluating the Impact of GenMark Dx ePlex® Blood Culture Identification (BCID) on Gram-negative Bloodstream Infections
por: Cumagun, Pia, et al.
Publicado: (2021)

359. The Clinical Utility of the GenMark Dx ePlex® Fungal Blood Culture Identification Panel
por: Carmona, Stefania, et al.
Publicado: (2022)

Clinical Performance of the Novel GenMark Dx ePlex Blood Culture ID Gram-Positive Panel
por: Carroll, Karen C., et al.
Publicado: (2020)

214. Prospective Evaluation of the GenMark Dx ePlex(®) Blood Culture Identification Gram Negative Panel
por: Meeder, Jeremy, et al.
Publicado: (2021)

200. Prospective Evaluation of the GenMark Dx ePlex(®) Blood Culture Identification Gram Positive Panel
por: Meeder, Jeremy, et al.
Publicado: (2021)

The impact of GenMark Dx ePlex blood-culture identification on the treatment and outcomes of gram-positive bacteremia
por: Kiszla, B. Matthew, et al.
Publicado: (2022)

Test Performance and Potential Clinical Utility of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel
por: McCarty, T. P., et al.
Publicado: (2023)

A Multicenter Clinical Study To Demonstrate the Diagnostic Accuracy of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel
por: Wolk, Donna M., et al.
Publicado: (2021)

1027. Earlier Is Better: Progress Toward Decreased Time to Optimal Therapy and Improved Antibiotic Stewardship for Gram-positive Bloodstream Infections Through Use of GenMark Dx ePlex system
por: White, Cameron, et al.
Publicado: (2021)

Evaluation of the Genmark ePlex® and QIAstat-Dx® respiratory pathogen panels in detecting bacterial targets in lower respiratory tract specimens
por: van Asten, Suzanne A. V., et al.
Publicado: (2021)

2749. Impact of rapid carbapenemase identification on management of patients with carbapenem-resistant Enterobacterales infections
por: Burke, Elysia, et al.
Publicado: (2023)

124. Impact of Levofloxacin MIC on Outcomes with Levofloxacin Step-down Therapy in Enterobacteriaceae Bloodstream Infections
por: White, Melissa, et al.
Publicado: (2019)

751. Impact of Changing from a Three-step to Two-step Testing Algorithm for the Diagnosis of Clostridioides difficile
por: Lapin, Jonathan, et al.
Publicado: (2021)

160. Antimicrobial Prescribing Patterns in Bloodstream Infections Caused by Cefepime-Susceptible Extended Spectrum β-lactamase Enterobacterales
por: O’Rourke, Emerald, et al.
Publicado: (2022)

Evaluation of the ePlex Blood Culture Identification Panels for Detection of Pathogens in Bloodstream Infections
por: Huang, Te-Din, et al.
Publicado: (2019)

168. Syndrome-Based Analysis of Oral Antimicrobial Stewardship Opportunities at Hospital Discharge
por: Cunningham, Jessica, et al.
Publicado: (2021)

1759. Risk Factors for OPAT-Related Adverse Drug Events: A Case-Control Study
por: Burke, Elysia, et al.
Publicado: (2022)

905. Impact of a Real-Time Electronic Alert on Antibiotic Treatment Duration for Pneumonia in Hospitalized Patients
por: Degnan, Kathleen, et al.
Publicado: (2022)

622. Evaluation of Vascular Access Device Selection in Patients Discharged on Outpatient Parenteral Antimicrobial Therapy
por: Hu, Jessica, et al.
Publicado: (2021)

275. Comparison of Cefazolin versus Nafcillin for Methicillin-Susceptible Staphylococcus aureus Bacteremia with a Deep-Seated Source
por: Mersinger, Katherine E, et al.
Publicado: (2020)

2174. Comparison of the Verigene® and the ePlex® Blood Culture Identification Panels for Gram-Positive and Gram-Negative Bloodstream Infections
por: Johnson, J Kristie, et al.
Publicado: (2019)

1012. Characterization of Antibiotic Superutilizers in the Inpatient Setting
por: Burns, Jonathan, et al.
Publicado: (2019)

54. Effectiveness of a Venous Catheter Stewardship Intervention Targeting Parenteral Antimicrobial Therapy at Hospital Discharge
por: Athans, Vasilios, et al.
Publicado: (2020)

Evaluation of point of care testing platform (ePLEX) for respiratory viral diagnosis
por: Guerendiain, Daniel, et al.
Publicado: (2016)

653. Comparison of Yeasts identification by Biofire, Culture and ePlex for Quality Assurance purpose
por: lin, jeffrey, et al.
Publicado: (2020)

1143 GenMark ESensor Respiratory Viral Panel in an Inpatient Pediatric Population
por: Oliver, Sara, et al.
Publicado: (2014)

The Penn Medicine COVID-19 Therapeutics Committee—Reflections on a Model for Rapid Evidence Review and Dynamic Practice Recommendations During a Public Health Emergency
por: Anesi, George L, et al.
Publicado: (2023)

164. Performance of ePlex® Blood Culture Identification Panels in Clinical Isolates and Characterization of Antimicrobial Stewardship Opportunities
por: Thomas, Jenni, et al.
Publicado: (2023)

Multicenter Evaluation of the ePlex Respiratory Pathogen Panel for the Detection of Viral and Bacterial Respiratory Tract Pathogens in Nasopharyngeal Swabs
por: Babady, N. Esther, et al.
Publicado: (2018)

Clinical implications of rapid ePlex® Respiratory Pathogen Panel testing compared to laboratory-developed real-time PCR
por: van Rijn, Anneloes L., et al.
Publicado: (2017)

Comparison of ePlex Respiratory Pathogen Panel with Laboratory-Developed Real-Time PCR Assays for Detection of Respiratory Pathogens
por: Nijhuis, R. H. T., et al.
Publicado: (2017)

285. Evaluation of the ePlex® Blood Culture Identification (BCID) Panels for Gram-positive/Gram-negative bacteria and yeasts
por: Chapin, Kimberle, et al.
Publicado: (2020)

153 Implementation of a Provider-Based Antimicrobial Stewardship Strategy at a Long Term Acute Care Hospital (LTACH) and Inpatient Physical Medicine and Rehabilitation (PMR) Facility
por: Rolek, Kiri, et al.
Publicado: (2014)

Evaluation of Microbiological Performance and the Potential Clinical Impact of the ePlex(®) Blood Culture Identification Panels for the Rapid Diagnosis of Bacteremia and Fungemia
por: Bryant, Sabrina, et al.
Publicado: (2020)

The 82-plex plasma protein signature that predicts increasing inflammation
por: Tepel, Martin, et al.
Publicado: (2015)

1146. Real-World Experience Highlighting Tocilizumab Use in the Treatment of COVID-19
por: Maguire, Christina, et al.
Publicado: (2022)

1074. Evaluation of a Pharmacist-led Antimicrobial and Anticoagulant Monitoring Initiative
por: Hsiang Lin, Wei, et al.
Publicado: (2019)

1814. External Validation of Precision Antibiotic Therapy for Enterococcal Bloodstream Infections
por: Lee, Tiffany, et al.
Publicado: (2018)

A Closer Look at the Laboratory Impact of Utilizing ePlex Blood Culture Identification Panels: a Workflow Analysis Using Rapid Molecular Detection for Positive Blood Cultures
por: Tansarli, Giannoula S., et al.
Publicado: (2022)

Comparative Performance of the Luminex NxTAG Respiratory Pathogen Panel, GenMark eSensor Respiratory Viral Panel, and BioFire FilmArray Respiratory Panel
por: Popowitch, Elena B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2ij4ghafad7iu74lnr411bfrq4